Teresa N Sparks1,2, Kao Thao1, Mary E Norton1,2. 1. Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California, San Francisco, San Francisco, California, USA. 2. Department of Pediatrics, University of California, San Francisco, San Francisco, California, USA.
Abstract
PURPOSE: To evaluate obstetric and neonatal outcomes as well as long-term neurodevelopmental outcomes and quality of life among prenatally detected cases of mosaic trisomy (MT16) and confined placental mosaicism (CPM) for trisomy 16. METHODS: We recruited participants for this cross-sectional study through an international registry of families with children diagnosed with MT16 or CPM. Parents were interviewed about expectations based on prenatal counseling as well as about actual perinatal outcomes, congenital anomalies, medical conditions, and school progress. Health-related quality of life (HRQOL) was assessed via the Pediatric Quality of Life Inventory 4.0 Generic Core Scales. RESULTS: Forty-four families were enrolled, and 68.2% of the children were female. Common complications were gestational hypertension (gHTN) or preeclampsia (38.1%), preterm delivery (PTD; 71.4%), cesarean delivery (CD; 73.8%), birth weight <10th percentile (73.8%), neonatal intensive care unit (NICU) admission (88.1%), and congenital anomalies (59.5%). However, 81.8% of school-aged children were entirely in mainstream classes, and median physical, psychosocial, and total HRQOL scores were high: 90.6 (34.4-100), 86.7 (35-100), and 84.8 (34.8-100), respectively (100 = optimal quality of life). CONCLUSION: Several obstetric and neonatal complications are common with pregnancies affected by MT16 or CPM. However, the majority of children demonstrate normal neurodevelopmental outcomes and high HRQOL.Genet Med advance online publication 06 April 2017.
PURPOSE: To evaluate obstetric and neonatal outcomes as well as long-term neurodevelopmental outcomes and quality of life among prenatally detected cases of mosaic trisomy (MT16) and confined placental mosaicism (CPM) for trisomy 16. METHODS: We recruited participants for this cross-sectional study through an international registry of families with children diagnosed with MT16 or CPM. Parents were interviewed about expectations based on prenatal counseling as well as about actual perinatal outcomes, congenital anomalies, medical conditions, and school progress. Health-related quality of life (HRQOL) was assessed via the Pediatric Quality of Life Inventory 4.0 Generic Core Scales. RESULTS: Forty-four families were enrolled, and 68.2% of the children were female. Common complications were gestational hypertension (gHTN) or preeclampsia (38.1%), preterm delivery (PTD; 71.4%), cesarean delivery (CD; 73.8%), birth weight <10th percentile (73.8%), neonatal intensive care unit (NICU) admission (88.1%), and congenital anomalies (59.5%). However, 81.8% of school-aged children were entirely in mainstream classes, and median physical, psychosocial, and total HRQOL scores were high: 90.6 (34.4-100), 86.7 (35-100), and 84.8 (34.8-100), respectively (100 = optimal quality of life). CONCLUSION: Several obstetric and neonatal complications are common with pregnancies affected by MT16 or CPM. However, the majority of children demonstrate normal neurodevelopmental outcomes and high HRQOL.Genet Med advance online publication 06 April 2017.
Authors: Stephanie E Hullmann; Jamie L Ryan; Rachelle R Ramsey; John M Chaney; Larry L Mullins Journal: Arthritis Care Res (Hoboken) Date: 2011-11 Impact factor: 4.794
Authors: K J Paulyson; D M Sherer; S L Christian; K M Lewis; D H Ledbetter; C M Salafia; J M Meck Journal: Prenat Diagn Date: 1996-11 Impact factor: 3.050
Authors: S Brisset; G Joly; C Ozilou; J-M Lapierre; Ph Gosset; M LeLorc'h; O Raoul; C Turleau; M Vekemans; S P Romana Journal: Am J Med Genet Date: 2002-12-15
Authors: Claudine Rieubland; David Francis; Leonie Houben; Sylvea Corrie; Agnes Bankier; Susan M White Journal: Am J Med Genet A Date: 2009-07 Impact factor: 2.802
Authors: Lore Lannoo; Khaila van Straaten; Jeroen Breckpot; Nathalie Brison; Luc De Catte; Eftychia Dimitriadou; Eric Legius; Hilde Peeters; Ilse Parijs; Olga Tsuiko; Leen Vancoillie; Joris Robert Vermeesch; Griet Van Buggenhout; Kris Van Den Bogaert; Kristel Van Calsteren; Koenraad Devriendt Journal: Eur J Hum Genet Date: 2022-07-27 Impact factor: 5.351
Authors: Giulia F Del Gobbo; Yue Yin; Sanaa Choufani; Emma A Butcher; John Wei; Evica Rajcan-Separovic; Hayley Bos; Peter von Dadelszen; Rosanna Weksberg; Wendy P Robinson; Ryan K C Yuen Journal: Mol Med Date: 2021-01-07 Impact factor: 6.354
Authors: Ekaterina N Tolmacheva; Stanislav A Vasilyev; Tatiana V Nikitina; Ekaterina S Lytkina; Elena A Sazhenova; Daria I Zhigalina; Oksana Yu Vasilyeva; Anton V Markov; Victoria V Demeneva; Liubov A Tashireva; Anna A Kashevarova; Igor N Lebedev Journal: Sci Rep Date: 2022-01-21 Impact factor: 4.379